Abstract
Objective This study is focused on the analysis of the spread of Covid-19 in Nigeria, applying statistical models and available data from the NCDC. We present an insight into the spread of Covid-19 in Nigeria in order to establish a suitable prediction model, which can be applied as a decision-supportive tool for assigning health interventions and mitigating the spread of the Covid-19 infection.
Methodology Daily spread data from February 27 to April 26, 2020, were collected to construct the autoregressive integrated moving average (ARIMA) model using the R software. Stability analysis and stationarity test, parameter test, and model diagnostic were also carried out. Finally, the fitting, selection and prediction accuracy of the ARIMA model was evaluated using the AICc model selection criteria.
Results The ARIMA (1,1,0) model was finally selected among ARIMA models based upon the parameter test and Box–Ljung test. A ten-day forecast was also made from the model, which shows a steep upward trend of the spread of the COVID-19 in Nigeria within the selected time frame.
Conclusion Federal Government of Nigeria through the presidential task force can apply the forecasted trend of much more spread to make more informed decisions on the additional measures in place to curb the spread of the virus. Application of the model can also assist in studying the effectiveness of the lockdown on the on the spread of Covid-19 in Nigeria.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data used from the Nigeria center for Disease Control (NCDC) is free and available for public use
